Document is current
Any future updates will be listed below
-
Authors
Simon, Arnaud
Girerd, Nicolas https://orcid.org/0000-0002-3278-2057
Jaisser, Frédéric
Bozec, Erwan
Lepage, Xavier
Mercklé, Ludovic
Rossignol, Patrick
Frimat, Luc
Girerd, Sophie
-
Funding
Funding for this research was provided by:
French Ministry of Health
- License Information
-
More Information
Article History
Received: 11 October 2024
Accepted: 3 October 2025
First Online: 7 November 2025
Declarations
:
: The trial has been approved by the French regulatory agency (Agence nationale de la sécurité du medicament et des produits de santé: ANSM) and the appropriate ethics committee (Comité de Protection des Personnes: CPP). Written informed consent will be obtained from all participants by investigators.
: All authors have read and approved the final submitted version of this manuscript.
: FJ received a research grant from Bayer and AstraZeneca. NG received honoraria from AstraZeneca, Bayer, Boehringer, Lilly, Novo Nordisk, Novartis, and Roche Diagnostics. The remaining authors declare that they have no competing interests.
